Hyperproliferation of B cells specific for a weakly immunogenic PorA in a meningococcal vaccine model
Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy
Vroege kenmerken en klinisch beloop van meningokokkenziekte in Nederland na de invoering van meningokokken C-vaccinatie
Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands